Michelle Dsurney, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 Overlook Rd Ste 200, Summit, NJ 07901 Phone: 908-522-5757 |
Mrs. Diane Fialka, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave., Summit, NJ 07901 Phone: 908-522-4684 Fax: 908-598-2388 |
Brittany E. Murphy, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 45 River Rd Ste 4, Summit, NJ 07901 Phone: 201-905-2515 |
Jessica Levy, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-4800 |
Jeanne Lessner, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 35 Beechwood Rd Ste 3a B, Integrated Behavioral Care Pa, Summit, NJ 07901 Phone: 908-766-1000 Fax: 908-598-2408 |
Diana Melendez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 908-522-3586 |
Emily Brogan Grigal, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 99 Beauvoir Ave, Summit, NJ 07901 Phone: 973-306-8347 |
News Archive
The document, which was commissioned by Rep. Beto O'Rourke, D-Texas, found wait times as long as 71 days for veterans who sought mental health treatment at the facility. This finding was very different from official statistics.
Researchers claim to have reproduced disease mechanisms due to coronavirus disease 2019 (COVID-19) in the fruit fly, Drosophila, while also providing proof of the efficacy of one drug against these disease processes. If validated, these findings represent a new understanding of how the virus causes neurological symptoms that could help develop more effective therapies.
Older people rushed to the emergency room are more likely to be living at home up to a year later if they receive a comprehensive and age-appropriate evaluation during their hospital stay.
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that enrollment has commenced at North American sites in its pivotal Phase 3 clinical trial program for BI 201335, the Company's investigational, oral protease inhibitor for the treatment of chronic hepatitis C virus (HCV).
Teavana Holdings, Inc. today announced financial results for the third quarter and fiscal year-to-date ended October 30, 2011.
› Verified 9 days ago